The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations

الملخص EN

Regulatory T cells (Treg cells) are considered one of the main dynamic cell types within the immune system.

Because Treg cells suppress immune responses, they have potential roles in immunological self-tolerance and may help to maintain immune homeostasis.

Promoting Treg cell function and increasing their numbers might be useful in treating autoimmune disorders, as well as preventing allograft rejection.

However, studies of mice and humans demonstrate that Treg cells promote cancer progression and suppress antitumor immunity.

Therefore, suppressing Treg cell function or reducing their numbers could support the immune system’s response to pathogenic microorganisms and tumors.

As a result, there is great interest in investigating the Treg cells role in the treatment of hematological and nonhematological malignancies.

Consequently, Treg cells could be a fundamentally important target for pathologies of the immune system.

Targeting effector Treg cells could help to distinguish and selectively decrease these cells while preserving other Treg cells needed to suppress autoimmunity.

Currently, a promising way to treat malignancies and other autoimmune disorders is stem cell transplantation.

Stem cell transplants (SCT) can help to manage the production of Treg cells and also may produce more efficient Treg cells, thereby suppressing clinical disease progression.

Specifically, mature T cells within the engrafted stem cells mediate this SCT beneficial effect.

During SCT, the recipient’s immune system is replaced with a donor, which allows for improved immune system function.

In addition, SCT can protect from disease relapse, as graft-versus-host disease (GvHD) in transplant patients can be protective against cancer recurrence.

The current review will define the role of regulatory T cells in treatment of malignancy.

Additionally, it will summarize current promising research regarding the utility of regulatory T cells in stem cell transplantation.